江苏恒瑞医药简介-PPT

JiangsuHengruiMedicineCo.,Ltd江苏恒瑞医药股份有限公司2006Bettermedicinestopeople’shealth关爱人类健康JiangsuHengruiMedicineCo.,IntroductionJiangsuHengruiMedicineEstablished:1970HeadOffice:Lianyungang,Jiangsu,ChinaPresident:Mr.PiaoyangSunEmployees:1800including:R&D230恒瑞医药始建于1970年，公司位于江苏连云港董事长孙飘扬公司现有员工2000人，研发人员230人MainBusinessesLineHengruimainlyproducesantineoplastics,cardiovascular,analgesic,antibiotics.HengruiwastheNo.1AntineoplasticsalesinChinaMarketin2003、2004.恒瑞主要从事抗肿瘤药、心血管类药、镇痛类药、抗生素的生产。2003、2004年抗肿瘤药销量全国排名第一。HengruiGroupJiangsuHengruiMedicineCo.,Ltd.PharmaceuticalsandR&DShanghaiHengruiMedicineCo.,Ltd.PharmaceuticalsandR&D☉☉成都上海☉连云港ShanghaiHengruiMedicine&ChengduHengruiMedicineWorkshop&EquipmentHengruihastwofactoryzones,theoldoneislocatedatXinpu,thenewoneislocatedatECO.&TECHDevelopmentZone.恒瑞现有两个厂区：新浦厂区开发区新厂区Workshop&EquipmentTheXinpufactoryisthemainareaofsynthesizingandproducingbulkdrugs,includingtwosolidpreparationwhichpassedtoGMPinspectionand6bulkdrugsworkshops.Itcanproduce20kindsofchemicalmedicines1.6billionpills,50tonsof40kindsofbulkdrugsperyear.新浦厂区主要是固体制剂与原料药生产地，拥有2个通过GMP认证的固体制剂车间、6个原料车间。年生产能力为西药20种16亿片，化学原料药40种50吨。HeadofficeWorkshop&EquipmentGMP固体制剂车间SolidPreparationWorkshop&EquipmentThenewfactoryhasanareaof30thousandofsquaremeters,whichbuiltpreparationworkshopsaccordingtoGMP,andimportedabatchofadvancedequipmentandproductionline.Nowthefactoryiscapableofproducing50millioninjections,2millionlyophilizedpowdersand2millionsterilesplitchargingpowder.开发区新厂区占地3万多平方米，新建了符合GMP要求的制剂车间，并已引进了一批国外的先进设备仪器，新增年产针剂5000万支、冻干粉针200万瓶、灭菌分装粉针200万瓶的生产能力。CapacityofJiangsuHengrui50millioninjections,2millionlyophilizedpowders2millionsterilesplitchargingpowder.500milliontroches12milliontransfusionbagsFreezeDryerImportedfromEDWARDSForm-Fill-SealLineSolidPreparationAuto-LineAuto-PackingLine●上海分公司2004年上半年建成投产。ShanghaiHengruiwasinproductioninJun.2004Subsidiarycompany－－ShanghaiHengruiShanghaiHengruiCampusSalesNetSalenetworkcoversallofthecountry.Thereare62saleofficesinsideChina.Salespersonsareover1300.ActivePharmaceuticalingredientsaremainlysoldtoUSAandEurope.,恒瑞有九个销售公司，在全国各地有80个办事处，共有1500名销售代表JinagsuHengruiSalesStatusTop5Productsin2004020406080100120140160180AihengTongaoLelangNuobangAisuUnit:MillionRMB●2001年恒瑞医药原料药异环磷酰胺、足叶乙甙、美司那、噻替派通过了美国FDA验证。Ifosfamide,Etoposide,MesnaandThiotepawereapprovedbyFDAin2001.FDAApprovingExportStatusOfRawChemicalMaterial010002000300040005000600020012002200320042005Unit:￥Tenthousand(RMB)R&DActivity研究与开发恒瑞拥有2个研究中心HengruiHasTwoR&DCenters•恒瑞连云港研究中心LianyungangR&DCenter人员ResearcherandEngineer：130Persons化学合成、植物药、中试研究、通用名药物ChemicalSynthesizing,PlantDrugs,ScaleTestBeforeProduction,GenericMedicines•恒瑞上海研究中心ShnaghaiR&DCenter人员ResearcherandEngineer：60Persons药物设计、化学合成、制剂研究、生物工程DrugDesign,ChemicalSynthesizing,PreparationImprovement,BiologyEngineeringR&DActivity研究化学药物ChemicalMedicine:•COX-2抑制剂InhibitorBNP909inPhaseIBNP811inPreclinical•糖尿病PPARγ激动剂DiabetesPPARγAgonist•抗肿瘤药物Antineoplastics•胃动力药Gastrokineticagents•抗生素AntibioticsR&DActivity研究植物药PlantDrugs•肝病治疗药LiverTreatmentDrugs•镇咳药Antitussivers•妇科用药GynecologicalDrugs生物工程BiologyEngineering•单克隆抗体MonoclonalAntibody•多肽合成PolypeptideSynthesis合作研究R&DCooperation•与美国Chiron公司合作研究CooperationDevelopmentwithChironinUSA:Eg5•与瑞典Medvir公司研究治疗CooperationwithMedvirCo.,inSwedenforDevelopmentofCOPDMedicineThanks!